BioCentury
ARTICLE | Clinical News

Tolcapone: Phase IIa data

November 9, 2015 8:00 AM UTC

An open-label, Spanish Phase IIa trial in 6 healthy volunteers and 15 FAP patients at different stages of disease progression and asymptomatic carriers with mutations in the TTR gene showed that singl...